MediciNova (TSE:4875) Additional Paid-In Capital : 円71,668.0 Mil(As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is MediciNova Additional Paid-In Capital?

MediciNova's quarterly additional paid-in capital declined from Sep. 2023 (円70,727.1 Mil) to Dec. 2023 (円68,844.6 Mil) but then increased from Dec. 2023 (円68,844.6 Mil) to Mar. 2024 (円71,668.0 Mil).

MediciNova's annual additional paid-in capital increased from Dec. 2021 (円54,274.2 Mil) to Dec. 2022 (円64,413.5 Mil) and increased from Dec. 2022 (円64,413.5 Mil) to Dec. 2023 (円68,844.6 Mil).

MediciNova Additional Paid-In Capital Historical Data

The historical data trend for MediciNova's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Additional Paid-In Capital Chart

MediciNova Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

48,442.59

47,153.85

54,274.16

64,413.45

68,844.61

MediciNova Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															63,870.42	67,592.78	70,727.13	68,844.61	71,667.97

MediciNova Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

MediciNova Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of MediciNova's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

MediciNova (TSE:4875) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (TSE:4875) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MNOV:USA

Address

4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037

Website

https://www.medicinova.com

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova (TSE:4875) Headlines

No Headlines